Zhejiang Huahai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Zhejiang Huahai Pharmaceutical has a total shareholder equity of CN¥9.0B and total debt of CN¥6.8B, which brings its debt-to-equity ratio to 76.4%. Its total assets and total liabilities are CN¥19.5B and CN¥10.5B respectively. Zhejiang Huahai Pharmaceutical's EBIT is CN¥1.6B making its interest coverage ratio 9.5. It has cash and short-term investments of CN¥1.7B.
Key information
76.4%
Debt to equity ratio
CN¥6.85b
Debt
| Interest coverage ratio | 9.5x |
| Cash | CN¥1.66b |
| Equity | CN¥8.96b |
| Total liabilities | CN¥10.55b |
| Total assets | CN¥19.51b |
Recent financial health updates
Here's Why Zhejiang Huahai Pharmaceutical (SHSE:600521) Has A Meaningful Debt Burden
Sep 25
Zhejiang Huahai Pharmaceutical (SHSE:600521) Takes On Some Risk With Its Use Of Debt
May 28Recent updates
Here's Why Zhejiang Huahai Pharmaceutical (SHSE:600521) Has A Meaningful Debt Burden
Sep 25Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Intrinsic Value Is Potentially 89% Above Its Share Price
Jun 20Zhejiang Huahai Pharmaceutical (SHSE:600521) Takes On Some Risk With Its Use Of Debt
May 28There May Be Some Bright Spots In Zhejiang Huahai Pharmaceutical's (SHSE:600521) Earnings
May 06Investors Don't See Light At End Of Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) Tunnel
Mar 22Financial Position Analysis
Short Term Liabilities: 600521's short term assets (CN¥8.1B) exceed its short term liabilities (CN¥5.7B).
Long Term Liabilities: 600521's short term assets (CN¥8.1B) exceed its long term liabilities (CN¥4.8B).
Debt to Equity History and Analysis
Debt Level: 600521's net debt to equity ratio (57.9%) is considered high.
Reducing Debt: 600521's debt to equity ratio has reduced from 93.8% to 76.4% over the past 5 years.
Debt Coverage: 600521's debt is well covered by operating cash flow (38.3%).
Interest Coverage: 600521's interest payments on its debt are well covered by EBIT (9.5x coverage).